1
Kimberly O Cameron, Paul A Dasilva Jardine, Robert L Rosati: 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis. Pfizer, Peter C Richardson, Gregg C Benson, Mervin E Brokke, September 3, 1996: US05552412 (71 worldwide citation)

Compounds of this formula ##STR1## are useful for treating or preventing, obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease.


2
John Slegers: Multiple membrane separation systems. Romicon, Mervin E Brokke, December 25, 1990: US04980066 (53 worldwide citation)

An improved membrane separation system is provided, which comprises a plurality of discrete membrane separation units, each membrane separation unit:


3
Nicholas A Saccomano, Fredric J Vinick: Aryl substituted nitrogen heterocyclic antidepressants. Pfizer, Peter C Richardson, J Trevor Lumb, Mervin E Brokke, July 7, 1992: US05128358 (46 worldwide citation)

Antidepressant agents having the formula ##STR1## wherein R.sup.1 is a polycycloalkyl group; R.sup.2 is methyl or ethyl, X is O; and Y comprises a 5-membered heterocyclic ring having one or two nitrogens.


4
Martha J Kelly: Preparation of alkylhydrazines. Rohm and Haas Company, Barbara V Maurer, Mervin E Brokke, September 4, 1990: US04954655 (45 worldwide citation)

This application relates to a process for preparing alkylhydrazines from an alkene and hydrazine with an acid catalyst. More particularly, it relates to a process for preparing t-butylhydrazine from hydrazine and isobutylene in aqueous acid.


5
Ivan G Otterness, Peter S Mezes, James T Downs, Kimberly S Johnson: Assays for measurement of protein fragments in biological media. Pfizer, Peter C Richardson, Gregg C Benson, Mervin E Brokke, February 29, 2000: US06030792 (43 worldwide citation)

This invention provides novel antibodies and engineered versions thereof and methodology for monitoring biological media for protein fragments, especially collagen fragments resulting from collagenase cleavage of type II collagen.


6
David A Clark, Steven W Goldstein, Gerald F Holland, Bernard Hulin, James P Rizzi: Thiazolidinedione hypoglycemic agents. Pfizer, Peter C Richardson, Gregg C Benson, Mervin E Brokke, June 29, 1993: US05223522 (31 worldwide citation)

Hypoglycemic thiazolidine-2,4-dione derivatives of the formula ##STR1## wherein the dotted line represents a bond or no bond;


7
Douglas J M Allen, Kevin M Nepveux: Azithromycin dihydrate. Pfizer, Peter C Richardson, Gregg C Benson, Mervin E Brokke, July 31, 2001: US06268489 (27 worldwide citation)

Non-hygroscopic, azithromycin (9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin) dihydrate and a process therefor.


8
David A Clark, Steven W Goldstein, Gerald F Holland, Bernard Hulin, James P Rizzi: Thiazolidinedione hypoglycemic agents. Pfizer, Peter C Richardson, J Trevor Lumb, Mervin E Brokke, June 9, 1992: US05120754 (27 worldwide citation)

Hypoglycemic thiazolidine-2,4-dione derivatives of the formula ##STR1## wherein the dotted line represents a bond or no bond; A and dB are each independently CH or N, with the proviso that when A or B is N, the other is CH;


9
David D Thompson: Estrogen agonists as remedies for prostate and cardiovascular diseases. Pfizer, Peter C Richardson, Gregg C Benson, Mervin E Brokke, August 15, 1995: US05441986 (27 worldwide citation)

Use of droloxifene in the treatment of benign prostatic hyperplasia, prostatic carcinoma and cardiovascular diseases.


10
David A Clark, Steven W Goldstein, Gerald F Holland, Bernard Hulin, James P Rizzi: Thiazolidinedione hypoglycemic agents. Pfizer, Peter C Richardson, J Trevor Lumb, Mervin E Brokke, October 29, 1991: US05061717 (26 worldwide citation)

Hypoglycemic thiazolidine-2,4-dione derivatives of the formula ##STR1## wherein the dotted line represents a bond or no bond; A and B are each independently CH or N, with the proviso that when A or B is N, the other is CH;